67 related articles for article (PubMed ID: 9063861)
1. Clinical trials referral resource. Clinical trials using compound 506U78.
Ho PT; Cheson BD; Phillips PH
Oncology (Williston Park); 1996 Dec; 10(12):1831-2. PubMed ID: 9063861
[No Abstract] [Full Text] [Related]
2. Nelarabine (Arranon) for T-cell acute lymphoblastic leukemia.
Med Lett Drugs Ther; 2006 Feb; 48(1228):14-5. PubMed ID: 16467734
[No Abstract] [Full Text] [Related]
3. Clofarabine.
Pui CH; Jeha S; Kirkpatrick P
Nat Rev Drug Discov; 2005 May; 4(5):369-70. PubMed ID: 15902772
[No Abstract] [Full Text] [Related]
4. Nelarabine: a novel purine antimetabolite antineoplastic agent.
Buie LW; Epstein SS; Lindley CM
Clin Ther; 2007 Sep; 29(9):1887-99. PubMed ID: 18035189
[TBL] [Abstract][Full Text] [Related]
5. Nelarabine.
Gandhi V; Keating MJ; Bate G; Kirkpatrick P
Nat Rev Drug Discov; 2006 Jan; 5(1):17-8. PubMed ID: 16485343
[No Abstract] [Full Text] [Related]
6. Nelarabine: efficacy in the treatment of clinical malignancies.
Roecker AM; Allison JC; Kisor DF
Future Oncol; 2006 Aug; 2(4):441-8. PubMed ID: 16922610
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials referral resource. Clinical trials for children with acute leukemia.
Smith MA; Phillips PH; Cheson BD
Oncology (Williston Park); 1996 Nov; 10(11):1662, 1665-6. PubMed ID: 8953587
[No Abstract] [Full Text] [Related]
8. New drug to treat rare leukemia and lymphoma.
FDA Consum; 2006; 40(1):4-5. PubMed ID: 16532541
[No Abstract] [Full Text] [Related]
9. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials referral resource.
Anderson BD; Schoenfeldt M
Oncology (Williston Park); 2005 Jan; 19(1):69-70, 73-4, 78. PubMed ID: 15743152
[No Abstract] [Full Text] [Related]
11. Clinical trials referral resource.
Cheson BD
Oncology (Williston Park); 1991 Feb; 5(2):116, 118. PubMed ID: 1848990
[No Abstract] [Full Text] [Related]
12. Clofarabine for treatment of acute lymphoblastic leukaemia in adults.
Rodríguez Vargas B; Sánchez Cuervo M; Bermejo Vicedo T
Farm Hosp; 2011; 35(1):47-9. PubMed ID: 20673734
[No Abstract] [Full Text] [Related]
13. Nelarabine: new drug. T-lymphoblastic leukaemia/lymphoma: more evaluation needed.
Prescrire Int; 2009 Feb; 18(99):3-5. PubMed ID: 19382393
[TBL] [Abstract][Full Text] [Related]
14. Rituximab as therapy for acute lymphoblastic leukemia.
Thomas DA
Clin Adv Hematol Oncol; 2010 Mar; 8(3):168-71. PubMed ID: 20400931
[No Abstract] [Full Text] [Related]
15. New antileukemic agents.
Mantadakis E; Kalmanti M
Pediatr Hematol Oncol; 2003; 20(3):173-85. PubMed ID: 12637214
[TBL] [Abstract][Full Text] [Related]
16. Drug evaluation: sapacitabine--an orally available antimetabolite in the treatment of cancer.
Galmarini CM
Curr Opin Investig Drugs; 2006 Jun; 7(6):565-73. PubMed ID: 16784028
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials referral resource. Current clinical trials in pediatric acute lymphoblastic leukemia.
Smith M; Newsome SY; Cheson BD
Oncology (Williston Park); 2000 Dec; 14(12):1720, 1723-5. PubMed ID: 11204374
[No Abstract] [Full Text] [Related]
18. Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Cohen MH; Johnson JR; Massie T; Sridhara R; McGuinn WD; Abraham S; Booth BP; Goheer MA; Morse D; Chen XH; Chidambaram N; Kenna L; Gobburu JV; Justice R; Pazdur R
Clin Cancer Res; 2006 Sep; 12(18):5329-35. PubMed ID: 17000665
[TBL] [Abstract][Full Text] [Related]
19. Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemia.
Thachil J
Leuk Res; 2007 Oct; 31(10):1452-3. PubMed ID: 17178159
[No Abstract] [Full Text] [Related]
20. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
Rubiales AS; del Valle ML
Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
